Adelaide-based medical technology company LBT Innovations (ASX: LBT) is lining up distributors in the lucrative US healthcare market for their pathology screening tech which is driven by artificial intelligence to maximise testing throughput in labs, providing healthcare professionals with accurate results faster. The Automated Plate Assessment System (APAS®) is a pathology AI device which automates
Read More
Deep in development of their Talking Heads platform that will revolutionise the way consumers interact with brands, artificial intelligence company Crowd Media (ASX: CM8) has secured a new revenue stream with licencing of their proprietary Conversational AI technology. The non-exclusive licence has been granted to digital media company Forever Holdings under SaaS terms valued at
Read More
While we may not realise it just yet, many of the services we utilise every day are being powered by artificial intelligence where big data centres have collected so much data about us, the user experience has become seamless, all the whilst saving billions of dollars. Although it is a harsh reality, automation by artificial
Read More
As long time leaders in the influencer and social media spaces, eCommence company Crowd Media (ASX: CM8) have had much of their digital market invaded through the pandemic, but emerged in a better than ever position thanks to prude capital management and their newly formed artificial intelligence alliance. Key to Crowd’s financial improvement has been
Read More
Leveraging their artificial intelligence capabilities for use in healthcare, medical imaging and research company Resonance Health (ASX: RHT) has received CE marking for its fully automated AI liver fat assessment software enabling commercialisation of their tech throughout Europe. This certification will allow HepaFat-AI to be sold in the European Economic Area, joining recent approvals in
Read More
Facetime conversations with your favourite celebrity could soon be a reality with eCommerce and artificial intelligence company Crowd Media (ASX: CM8) securing a vital partnership that will provide access to the best-in-class voice cloning technology. The partnership is with Europe-based synthetic media company Aflorithmic Labs (AFLR) and has been entered into alongside a strategic investment
Read More